Top compounds associated with response to EIF2B3


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.058 0.1
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA AR-42 GDSC1000 pan-cancer AAC 0.05 0.1
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA AZD0530 CCLE pan-cancer AAC -0.073 0.1
mRNA AS605240 GDSC1000 pan-cancer AAC -0.054 0.1
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.059 0.1
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
Download CSV